Keren-Or Amar
Director/Board Member at NewStem Ltd.
Profile
Dr. Keren-Or Amar is Vice President of Business Development at Yissum where she specializes in pursuing commercial partnerships for researchers from Hebrew University’s Medical and Life Sciences faculties.
Keren-Or brings to Yissum over 10 years of experience in business development, medical marketing, strategic planning, and market research.
Prior to joining Yissum, Keren-Or served as Global Medical Marketing Manager at Panaxia Pharmaceutical, General Manager at ShizimXL, a Medical Devices Accelerator, and the Business Development Manager at Cann10 Accelerator for Medical Cannabis.
Keren-Or also established and managed the Research and Development Authority at Shaare Zedek Medical Center and was responsible for the commercialization activities of projects that came from its medical staff.
Keren-Or completed her post-doctoral research at Hebrew University’s Faculty of Medicine.
She holds a Ph.D in Life Sciences as well as a Master of Law from Bar-Ilan University.
She completed her M.Sc and B.Sc in Biology at the Technion.
Keren-Or Amar active positions
| Companies | Position | Start |
|---|---|---|
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Private Equity Investor | 2020-04-30 |
Bionanosim (BNS) Ltd.
 Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | Director/Board Member | 2020-05-31 |
NewStem Ltd.
 NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah. | Director/Board Member | 2021-05-31 |
Former positions of Keren-Or Amar
| Companies | Position | End |
|---|---|---|
| Scentech Medical Technologies Ltd. | Director/Board Member | 2022-08-30 |
Training of Keren-Or Amar
| Technion-Israel Institute of Technology | Graduate Degree |
| Bar-Ilan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Finance |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | Health Technology |
NewStem Ltd.
NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah. | Technology Services |
| Scentech Medical Technologies Ltd. |
- Stock Market
- Insiders
- Keren-Or Amar